Management of hepatitis C: current and future perspectives.
about
Interferon-gamma inhibits interferon-alpha signalling in hepatic cells: evidence for the involvement of STAT1 induction and hyperexpression of STAT1 in chronic hepatitis CInvolvement of PKR and RNase L in translational control and induction of apoptosis after Hepatitis C polyprotein expression from a vaccinia virus recombinantRegulated and Liver-Specific Tamarin Alpha Interferon Gene Delivery by a Helper-Dependent Adenoviral VectorCell clones selected from the Huh7 human hepatoma cell line support efficient replication of a subgenomic GB virus B replicon.Gene Expression Profiling of the Cellular Transcriptional Network Regulated by Alpha/Beta Interferon and Its Partial Attenuation by the Hepatitis C Virus Nonstructural 5A ProteinHepatitis C virus replication is directly inhibited by IFN-alpha in a full-length binary expression system.Identification and development of fucosylated glycoproteins as biomarkers of primary hepatocellular carcinoma.Cost-Effectiveness of Hepatitis C Treatment for People Who Inject Drugs and the Impact of the Type of Epidemic; Extrapolating from Amsterdam, the NetherlandsBlood micronutrient, oxidative stress, and viral load in patients with chronic hepatitis C.Persistent oxidative stress in patients with chronic active hepatitis-C infection after antiviral therapy failure.Glycosylation and liver cancer.Levels of Schistosoma mansoni Circulating Antigen in Chronic Hepatitis C Patients with Different Stages of Liver Fibrosis.Examination of the activity of camel milk casein against hepatitis C virus (genotype-4a) and its apoptotic potential in hepatoma and hela cell lines.Activation of interferon-stimulated response element in huh-7 cells replicating hepatitis C virus subgenomic RNA.Determination of the hepatitis C virus subtype: comparison of sequencing and reverse hybridization assays.Genetic predisposition of responsiveness to therapy for chronic hepatitis C.
P2860
Q24530717-B74E1B1C-F04E-440F-BEF9-45FF7CCBAE5CQ24814549-D5336292-9D31-457B-902B-3244F8921829Q27469612-EC6CD421-51F1-44DB-B448-50CCDC63D976Q27472890-5166A2E5-3105-4129-8207-3AF0BF55DDA3Q27473508-F0E8BE07-6919-41C1-AB1C-5C10144E271CQ33934023-68E3A79A-5FF2-4C43-9870-82C1E6C75E10Q35592640-21798897-2E41-4F9F-9C5A-069809C3E307Q36155257-826FABFE-5CD7-4BCC-883D-EDA663727964Q36190363-48F255EA-F484-414D-AE38-F82F213EABF6Q36490941-CC12EE37-3A7E-4DA1-AD51-C478E60D27CAQ38366329-CD67A666-76A6-440A-BC48-04C7FDC37E70Q38883241-57E4F759-7CEC-4E03-A1E8-0D621A6F1BC4Q39701870-6D3BDB8D-5049-46A3-926F-84083189CE08Q40409455-3945D42A-471F-434C-BF8F-C79D004F4531Q43036114-F3F5842F-7C42-44B9-8FF0-0F80A1DA82A2Q50575681-D63E5D6F-9619-4A93-B8DB-915CA1A5064F
P2860
Management of hepatitis C: current and future perspectives.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
name
Management of hepatitis C: current and future perspectives.
@ast
Management of hepatitis C: current and future perspectives.
@en
type
label
Management of hepatitis C: current and future perspectives.
@ast
Management of hepatitis C: current and future perspectives.
@en
prefLabel
Management of hepatitis C: current and future perspectives.
@ast
Management of hepatitis C: current and future perspectives.
@en
P1476
Management of hepatitis C: current and future perspectives.
@en
P2093
Hoofnagle JH
P304
P356
10.1016/S0168-8278(99)80414-0
P478
31 Suppl 1
P577
1999-01-01T00:00:00Z